ZBH vs ALGN — Key Metrics
| Metric | ZBH (ZIMMER BIOMET HOLDINGS INC) | ALGN (ALIGN TECHNOLOGY INC) |
|---|---|---|
| Price | 103.32 | 163.96 |
| Market Cap | 19.55 Billion | 11.56 Billion |
| P/E (TTM) | 26.03 | 23.83 |
| P/B (Quarterly) | 1.639 | 2.7 |
| P/S (TTM) | 2.28 | 2.78 |
| Net Profit Margin (TTM) | 9.0 | 11.8 |
| Gross Margin (TTM) | 69.7 | 69.1 |
| ROE (TTM) | 6.1 | 11.8 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Underperform
Outperform
Recommendation Summary
Stock ZBH is projected to underperform the market, stock ALGN is projected to outperform the market. Upfront Recommendation: ALGN.
Financial Metrics
| ZBH | Metrics | ALGN |
|---|---|---|
| $103.32 | Price | $163.96 |
| — | Market Capitalization | — |
| 26.03 | Price to Earnings Ratio | 23.83 |
| 2.28 | Price to Sales | 2.78 |
| 15.1 | Price to FCF Ratio | 17.93 |
| 3.27 | Price to Gross Profit | 4.02 |
| 45.18 | Price to R&D | 30.61 |
| 3.81 | Price to Current Assets | 4.24 |
ZBH vs ALGN at a glance
Zimmer Biomet Holdings INC (ZBH) and Align Technology INC (ALGN) are both Medical Devices companies in the Healthcare sector. ZBH is the larger, at $19.6 billion in market value against $11.6 billion for ALGN, about 1.7 times the size.
On trailing-twelve-month figures, ZBH trades at 26.0 times trailing earnings and ALGN at 23.8; net profit margins are 9.0% and 11.8%.
The Upfront Investment model currently rates ZBH Underperform and ALGN Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.